This article reflects personal views and does not represent any organization or company. If you need any medical assistance, please consult a healthcare professional.
Background:
My initial encounter with low-intensity electrostimulation was to address premature ejaculation. The cause of my PE was relatively straightforward — primarily the result of habitually rapid ejaculation during college (in middle and high school, masturbation led to slow ejaculation, but prolonged rapid ejaculation in college caused some degree of PE). I later fully resolved the issue in a short period through behavioral therapy combined with low-intensity electrostimulation, though I now face a degree of ejaculatory difficulty (difficulty achieving ejaculation during prolonged sexual activity).
The above is not the focus of this discussion, but through that experience I discovered that low-intensity electrostimulation may have a positive effect on enhancement. I recently discussed this with friends and reviewed some literature and resources. Those who have followed my journey over the long term know that my enhancement results have been quite good — partly due to consistent training, and partly, I believe, due to low-intensity electrostimulation. I share the following for your reference. This discussion is speculative only; the equipment is low-cost, and you may try it as needed. A product link is provided at the end of the article.
Low-intensity electrostimulation (LIES) shows potential for improving penile corpora cavernosa or penile function, especially in treating neurogenic erectile dysfunction (ED) and promoting nerve regeneration. This is primarily achieved through stimulation of the cavernous nerves, thereby affecting the neurophysiological processes required for erectile function.
Effect of Low-Intensity Electrostimulation (LIES) on Cavernous Nerve Injury
A study conducted in a male Sprague-Dawley rat model evaluated the effect of LIES on nerve regeneration and erectile function recovery after cavernous nerve injury (BCNI). The study found that erectile function (measured by intracavernous pressure) significantly decreased 7 days after BCNI, but LIES treatment significantly improved erectile function.
The effects of LIES on the penile corpora cavernosa and neural structure are mainly reflected in the following aspects:
Reducing oxidative stress and inflammation: After BCNI, reactive oxygen species (DHE) in the corpora cavernosa increased, and LIES restored them to normal levels. At the same time, the expression of inflammatory proteins such as TGF-β1, IL-6, and CRP in the penis increased after BCNI, and LIES also restored them to normal.
Improving tissue remodeling: BCNI led to a decrease in the ratio of α-SMA and/or total collagen in the penis, indicating remodeling of erectile tissue. LIES treatment restored these markers to normal, suggesting a role in preventing cavernosal fibrosis and structural damage.
Promoting nerve regeneration: After BCNI, the degree of myelination of the cavernous nerves and the number of nNOS (neuronal nitric oxide synthase) positive cells decreased, and LIES restored them to normal. In addition, BCNI caused an increase in the number of apoptotic neural cells in the dorsal nerve of the penis, and LIES significantly reduced the number of apoptotic cells, indicating that LIES helps protect neural structure and promote nerve regeneration.
Cellular signaling pathways: In the LIES group, the protein expression ratios of p-ERK/ERK and p-AKT/AKT increased, suggesting that LIES may promote nerve regeneration and tissue repair by activating these signaling pathways.
This study emphasizes that LIES may provide a new potential tool for the rehabilitation and management of (neurogenic) erectile dysfunction after radical prostatectomy, helping to enhance erectile function recovery and minimize the side effects of surgery. However, this study was conducted in an animal model, and the results need further validation in humans.
Application of Electrophysiological Techniques in the Diagnosis and Treatment of Erectile Dysfunction
In addition to LIES, other forms of electrical stimulation have been explored for the diagnosis and treatment of erectile dysfunction. A new electrophysiological technique combining medical infrared thermography with low-frequency (20-50 Hz) neuromuscular electrical stimulation has achieved good results in the prevention and treatment of female pelvic floor dysfunction. Since the male reproductive organs are located in the pelvic floor region, their normal function is closely related to the blood vessels, nerves, and muscles of the pelvic floor, so this technique has been applied to the treatment of male erectile dysfunction. By observing the penis, groin, and lower abdomen, this technique enables precise diagnosis and treatment, and has shown effectiveness in improving the self-reported erectile status and erectile function scores of patients with erectile dysfunction.
The Role of Neuromodulation in Erectile Dysfunction
Broadly defined neuromodulation, including electrical stimulation, has been studied for decades for the treatment of various diseases. Its mechanism is not fully elucidated, but a large number of clinical successes demonstrate its efficacy and durability.
Neurogenic erection: Penile erection is a complex neurovascular event regulated by psychological and hormonal factors, involving complex interactions between the central nervous system and local factors. The discovery of nitric oxide (NO) as an intercellular messenger or neurotransmitter provided an important mechanism for understanding penile physiological and pathophysiological events, and drove the development of new therapies based on novel concepts of molecular and cellular interactions. Neurogenic NO plays a key role in penile erection, as pharmacological neuromodulation is an important step in achieving penile erection. Erectile dysfunction is usually caused by impaired formation and action of NO. Therefore, supplementing NO or intracellular cyclic guanosine monophosphate (cGMP) is considered the most promising measure for treating erectile dysfunction.
Sacral nerve stimulation: Stimulating the sacral nerve roots can induce penile erection. A study in anesthetized cats showed that stimulation of the S1 or S2 ventral roots (at 30-40 Hz) caused pronounced penile erection and rigidity, and significantly increased penile pressure. Simultaneous stimulation of the S1 or S2 dorsal and ventral roots (at 30 Hz) also produced a sustained increase in penile pressure; even after complete spinal cord transection at the T9-T10 level, this stimulation could induce significant and sustainable increases in penile pressure. This suggests that by minimally invasive surgery inserting electrodes into the sacral foramina to stimulate the sacral nerve roots, it may be possible to develop a new type of neuromodulation device to restore penile erection after spinal cord injury.
Cavernous nerve mapping: Although nerve-sparing prostatectomy is widely used, the results of erectile function recovery are often unsatisfactory. The concept of intraoperative cavernous nerve stimulation is reasonable. The cavernous nerves are usually difficult to visualize and have variable courses. Nerve stimulation can elicit a penile tumescence response, manifested as a slight increase in penile circumference and blood flow. Proximal nerve stimulation immediately after prostatectomy can determine whether nerve continuity is maintained and predict recovery of erectile function. The Cavermap system (Uromed Corporation, Boston, MA, USA) allows intraoperative nerve stimulation and monitoring of tumescence. A multicenter study showed that Cavermap-assisted prostatectomy had a significant advantage in nocturnal erection duration at one year. Other methods, such as using the device for sural or genitofemoral nerve grafting, nerve stimulation during cystectomy or abdominoperineal resection, and direct monitoring of cavernous pressure during nerve stimulation, are also being explored and await further evaluation.
Other Conservative Treatments
In addition to electrical stimulation and neuromodulation, other conservative treatments have been used for urological conditions, including pelvic floor muscle training, biofeedback, extracorporeal magnetic innervation (ExMI), compression devices (penile clamps), and lifestyle changes. Although these methods have been studied for treating post-prostatectomy incontinence, there is less evidence and incomplete support for their direct effect on erectile dysfunction, especially when compared with electrical stimulation.
Summary
Low-intensity electrostimulation, especially LIES, shows significant potential for improving penile corpora cavernosa and erectile function, primarily by promoting nerve regeneration, reducing oxidative stress, inhibiting inflammatory responses, and improving tissue remodeling. In addition, electrophysiological techniques that stimulate the sacral nerve roots have also been shown to induce penile erection, providing a new therapeutic direction for erectile function recovery after spinal cord injury. Although most of these studies are still at the animal model stage, they provide promising leads and directions for the future treatment of human erectile dysfunction, especially neurogenic ED. Neuromodulation, including electrical stimulation, is expected to become a first-line treatment for urological conditions (such as erectile dysfunction), thereby reducing reliance on medication or invasive surgery.
Product link:
https://mobile.yangkeduo.com/goods2.html?ps=B19EDpYO36
Open via Pinduoduo.
References for this article:
Urol Clin North Am. 2005 Feb;32(1):59-63. doi: 10.1016/j.ucl.2004.10.002.
Pharmacol Ther. 2005 May;106(2):233-66. doi: 10.1016/j.pharmthera.2004.11.011. Epub 2005 Mar 2.
Hum Reprod Update. 1999 Sep-Oct;5(5):448-74. doi: 10.1093/humupd/5.5.448.
Acta Pharmacol Sin. 2007 Jun;28(6):751-5. doi: 10.1111/j.1745-7254.2007.00584.x.
Int J Impot Res. 2004 Dec;16(6):505-11. doi: 10.1038/sj.ijir.3901233.
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD001843. doi: 10.1002/14651858.CD001843.pub5.
J Vis Exp. 2022 Nov 4(189). doi: 10.3791/63851.
Neuromodulation. 2023 Dec;26(8):1817-1822. doi: 10.1016/j.neurom.2022.06.003. Epub 2022 Aug 6.
BJU Int. 2004 Jan;93(1):9-13. doi: 10.1111/j.1464-410x.2004.04546.x.
J Sex Med. 2022 May;19(5):686-696. doi: 10.1016/j.jsxm.2022.02.004. Epub 2022 Mar 11.
Coming next: Penile Mondor's Disease and Sclerosing Lymphangitis of the Penis.